Wednesday, November 19, 2025 CO7 - systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis of individual patient data from randomised phase III trials comparing surgery plus systemic chemotherapy with surgery alone in patients with CRCLM. Analyses were performed in the overall intention-to-treat (ITT) population, in patients who had curative-intent surgery (resected population), and in those who received post-operative chemotherapy only. The primary endpoint was progression-free survival (PFS). Bregni G, Leurquin B, Giasafaki P, Takemura N, Kokudo N, Hasegawa K, Matsuyama Y, Nishioka Y, Aparicio T, Guimbaud R, Malicot KL, Tu D, O'Callaghan C, Lutz MP, Fontana E, Moehler M, Mauer ME, Sclafani F. Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis (ONLINE). European Journal of Cancer 2025. https://www.sciencedirect.com/science/article/pii/S0959804925009785
